HEADER TRANSCRIPTION 04-JUN-12 4AWJ TITLE PVHL:ELOB:ELOC COMPLEX, IN COMPLEX WITH CAPPED HYDROXYPROLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; COMPND 3 CHAIN: A, D, G, J; COMPND 4 FRAGMENT: RESIDUES 1-104; COMPND 5 SYNONYM: ELONGIN 18 KDA SUBUNIT, ELONGIN-B, ELOB, RNA POLYMERASE II COMPND 6 TRANSCRIPTION FACTOR SIII SUBUNIT B, SIII P18; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; COMPND 10 CHAIN: B, E, H, K; COMPND 11 FRAGMENT: RESIDUES 17-112; COMPND 12 SYNONYM: ELONGIN 15 KDA SUBUNIT, ELONGIN-C, ELOC, RNA POLYMERASE II COMPND 13 TRANSCRIPTION FACTOR SIII SUBUNIT C, SIII P15; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: EXTRA M AT N-TERMINUS AS RESULT OF CLONING; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 18 CHAIN: C, F, I, L; COMPND 19 FRAGMENT: RESIDUES 54-213; COMPND 20 SYNONYM: PROTEIN G7, PVHL; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PDUET1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PCDF_DUET1; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_VECTOR: PET28 KEYWDS TRANSCRIPTION, E3 UBIQUITIN LIGASE, TUMOR SUPRESSOR EXPDTA X-RAY DIFFRACTION AUTHOR I.VAN MOLLE,A.THOMANN,D.L.BUCKLEY,E.C.SO,S.LANG,C.M.CREWS,A.CIULLI REVDAT 1 14-NOV-12 4AWJ 0 JRNL AUTH I.VAN MOLLE,A.THOMANN,D.L.BUCKLEY,E.C.SO,S.LANG,C.M.CREWS, JRNL AUTH 2 A.CIULLI JRNL TITL DISSECTING FRAGMENT-BASED LEAD DISCOVERY AT THE VON HIPPEL- JRNL TITL 2 LINDAU PROTEIN:HYPOXIA INDUCIBLE FACTOR 1ALPHA PROTEIN- JRNL TITL 3 PROTEIN INTERFACE. JRNL REF CHEM.BIOL. V. 19 1300 2012 JRNL REFN ISSN 1879-1301 JRNL PMID 23102223 JRNL DOI 10.1016/J.CHEMBIOL.2012.08.015 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.500 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.536 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.01 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.89 REMARK 3 NUMBER OF REFLECTIONS : 56672 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.2224 REMARK 3 R VALUE (WORKING SET) : 0.2202 REMARK 3 FREE R VALUE : 0.2636 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2834 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5377 - 6.7602 0.99 2947 155 0.2054 0.2205 REMARK 3 2 6.7602 - 5.3763 1.00 2807 148 0.2376 0.2646 REMARK 3 3 5.3763 - 4.6998 1.00 2748 145 0.1848 0.2219 REMARK 3 4 4.6998 - 4.2715 1.00 2725 143 0.1625 0.2016 REMARK 3 5 4.2715 - 3.9661 1.00 2730 144 0.1847 0.2323 REMARK 3 6 3.9661 - 3.7327 1.00 2679 141 0.2084 0.2263 REMARK 3 7 3.7327 - 3.5461 1.00 2706 142 0.2240 0.2748 REMARK 3 8 3.5461 - 3.3920 1.00 2688 141 0.2303 0.2653 REMARK 3 9 3.3920 - 3.2616 1.00 2659 140 0.2361 0.3293 REMARK 3 10 3.2616 - 3.1492 1.00 2670 141 0.2328 0.2686 REMARK 3 11 3.1492 - 3.0508 1.00 2673 140 0.2436 0.2773 REMARK 3 12 3.0508 - 2.9637 1.00 2674 141 0.2430 0.3082 REMARK 3 13 2.9637 - 2.8857 1.00 2630 139 0.2371 0.3066 REMARK 3 14 2.8857 - 2.8154 1.00 2645 139 0.2516 0.3419 REMARK 3 15 2.8154 - 2.7514 1.00 2611 137 0.2525 0.2825 REMARK 3 16 2.7514 - 2.6929 1.00 2685 142 0.2602 0.3333 REMARK 3 17 2.6929 - 2.6391 1.00 2648 139 0.2810 0.3281 REMARK 3 18 2.6391 - 2.5893 1.00 2628 138 0.2970 0.3792 REMARK 3 19 2.5893 - 2.5431 1.00 2645 140 0.3096 0.4216 REMARK 3 20 2.5431 - 2.5000 1.00 2640 139 0.3218 0.3718 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.311 REMARK 3 B_SOL : 19.169 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.41 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 13.6276 REMARK 3 B22 (A**2) : 13.6276 REMARK 3 B33 (A**2) : 4.2148 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 0.0000 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 10721 REMARK 3 ANGLE : 0.634 14573 REMARK 3 CHIRALITY : 0.044 1666 REMARK 3 PLANARITY : 0.003 1888 REMARK 3 DIHEDRAL : 12.604 3971 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 11.7793 30.0951 23.9475 REMARK 3 T TENSOR REMARK 3 T11: 0.2767 T22: -0.2000 REMARK 3 T33: 0.0383 T12: -0.0455 REMARK 3 T13: 0.1282 T23: 0.1153 REMARK 3 L TENSOR REMARK 3 L11: 0.0427 L22: 0.1008 REMARK 3 L33: -0.0299 L12: -0.0096 REMARK 3 L13: 0.0549 L23: 0.0020 REMARK 3 S TENSOR REMARK 3 S11: 0.0040 S12: -0.0040 S13: -0.0083 REMARK 3 S21: -0.0796 S22: -0.0517 S23: 0.0263 REMARK 3 S31: 0.0128 S32: -0.0360 S33: 0.0051 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4AWJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUN-12. REMARK 100 THE PDBE ID CODE IS EBI-52750. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56728 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.50 REMARK 200 RESOLUTION RANGE LOW (A) : 30.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.6 REMARK 200 R MERGE (I) : 0.11 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.34 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.7 REMARK 200 R MERGE FOR SHELL (I) : 0.76 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.25 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA CACODYLATE PH 6.0, 0.2 M MG REMARK 280 ACETATE, 15% PEG3350, 5 MM DTT REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 181.02000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.51000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 271.53000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 181.02000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 271.53000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 90.51000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2025 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 82 REMARK 465 LYS A 104 REMARK 465 MET B 16 REMARK 465 GLY B 48 REMARK 465 PRO B 49 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLU B 56 REMARK 465 GLY C 51 REMARK 465 SER C 52 REMARK 465 HIS C 53 REMARK 465 MET C 54 REMARK 465 GLU C 55 REMARK 465 ALA C 56 REMARK 465 GLY C 57 REMARK 465 ARG C 58 REMARK 465 PRO C 59 REMARK 465 ARG C 60 REMARK 465 PRO C 61 REMARK 465 ASP C 143 REMARK 465 GLY C 144 REMARK 465 GLN C 145 REMARK 465 LEU C 201 REMARK 465 THR C 202 REMARK 465 GLN C 203 REMARK 465 GLU C 204 REMARK 465 ARG C 205 REMARK 465 ILE C 206 REMARK 465 ALA C 207 REMARK 465 HIS C 208 REMARK 465 GLN C 209 REMARK 465 ARG C 210 REMARK 465 MET C 211 REMARK 465 GLY C 212 REMARK 465 ASP C 213 REMARK 465 ALA D 81 REMARK 465 ASP D 82 REMARK 465 VAL D 102 REMARK 465 MET D 103 REMARK 465 LYS D 104 REMARK 465 MET E 16 REMARK 465 GLY E 48 REMARK 465 PRO E 49 REMARK 465 GLY E 50 REMARK 465 GLN E 51 REMARK 465 PHE E 52 REMARK 465 ALA E 53 REMARK 465 GLU E 54 REMARK 465 ASN E 55 REMARK 465 GLU E 56 REMARK 465 GLY F 51 REMARK 465 SER F 52 REMARK 465 HIS F 53 REMARK 465 MET F 54 REMARK 465 GLU F 55 REMARK 465 ALA F 56 REMARK 465 GLY F 57 REMARK 465 ARG F 58 REMARK 465 PRO F 59 REMARK 465 ARG F 60 REMARK 465 PRO F 61 REMARK 465 VAL F 62 REMARK 465 ARG F 205 REMARK 465 ILE F 206 REMARK 465 ALA F 207 REMARK 465 HIS F 208 REMARK 465 GLN F 209 REMARK 465 ARG F 210 REMARK 465 MET F 211 REMARK 465 GLY F 212 REMARK 465 ASP F 213 REMARK 465 LYS G 104 REMARK 465 MET H 16 REMARK 465 PRO H 49 REMARK 465 GLY H 50 REMARK 465 GLN H 51 REMARK 465 PHE H 52 REMARK 465 ALA H 53 REMARK 465 GLU H 54 REMARK 465 ASN H 55 REMARK 465 GLU H 56 REMARK 465 THR H 57 REMARK 465 GLY I 51 REMARK 465 SER I 52 REMARK 465 HIS I 53 REMARK 465 MET I 54 REMARK 465 GLU I 55 REMARK 465 ALA I 56 REMARK 465 GLY I 57 REMARK 465 ARG I 58 REMARK 465 PRO I 59 REMARK 465 ARG I 60 REMARK 465 PRO I 61 REMARK 465 ILE I 206 REMARK 465 ALA I 207 REMARK 465 HIS I 208 REMARK 465 GLN I 209 REMARK 465 ARG I 210 REMARK 465 MET I 211 REMARK 465 GLY I 212 REMARK 465 ASP I 213 REMARK 465 LYS J 104 REMARK 465 SER K 47 REMARK 465 GLY K 48 REMARK 465 PRO K 49 REMARK 465 GLY K 50 REMARK 465 GLN K 51 REMARK 465 PHE K 52 REMARK 465 ALA K 53 REMARK 465 GLU K 54 REMARK 465 ASN K 55 REMARK 465 GLU K 56 REMARK 465 THR K 57 REMARK 465 GLY L 51 REMARK 465 SER L 52 REMARK 465 HIS L 53 REMARK 465 MET L 54 REMARK 465 GLU L 55 REMARK 465 ALA L 56 REMARK 465 GLY L 57 REMARK 465 ARG L 58 REMARK 465 PRO L 59 REMARK 465 ARG L 60 REMARK 465 PRO L 61 REMARK 465 ILE L 206 REMARK 465 ALA L 207 REMARK 465 HIS L 208 REMARK 465 GLN L 209 REMARK 465 ARG L 210 REMARK 465 MET L 211 REMARK 465 GLY L 212 REMARK 465 ASP L 213 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 83 CG OD1 OD2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 ASP A 101 CG OD1 OD2 REMARK 470 VAL A 102 CG1 CG2 REMARK 470 GLU B 34 CD OE1 OE2 REMARK 470 LYS B 43 CE NZ REMARK 470 ASN B 85 CG OD1 ND2 REMARK 470 VAL C 62 CG1 CG2 REMARK 470 ARG C 64 NE CZ NH1 NH2 REMARK 470 ARG C 69 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 73 CG CD OE1 NE2 REMARK 470 LEU C 140 CG CD1 CD2 REMARK 470 VAL C 142 CG1 CG2 REMARK 470 LYS C 171 CG CD CE NZ REMARK 470 ARG C 176 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 177 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 182 CG CD NE CZ NH1 NH2 REMARK 470 TYR C 185 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN C 195 CG CD OE1 NE2 REMARK 470 LYS C 196 CG CD CE NZ REMARK 470 MET D 1 CG SD CE REMARK 470 ARG D 9 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 19 CD CE NZ REMARK 470 ASP D 83 CG OD1 OD2 REMARK 470 GLU D 98 CG CD OE1 OE2 REMARK 470 LEU D 99 CG CD1 CD2 REMARK 470 PRO D 100 CG CD REMARK 470 LYS E 43 CE NZ REMARK 470 SER E 47 OG REMARK 470 THR E 57 OG1 CG2 REMARK 470 ARG E 63 CG CD NE CZ NH1 NH2 REMARK 470 ASN E 85 CG OD1 ND2 REMARK 470 ARG F 69 CG CD NE CZ NH1 NH2 REMARK 470 GLN F 73 CD OE1 NE2 REMARK 470 ARG F 108 CZ NH1 NH2 REMARK 470 ARG F 113 NE CZ NH1 NH2 REMARK 470 GLU F 134 CG CD OE1 OE2 REMARK 470 GLN F 145 CG CD OE1 NE2 REMARK 470 LYS F 171 CG CD CE NZ REMARK 470 GLU F 173 CG CD OE1 OE2 REMARK 470 ARG F 176 CG CD NE CZ NH1 NH2 REMARK 470 ARG F 177 CG CD NE CZ NH1 NH2 REMARK 470 ARG F 182 CG CD NE CZ NH1 NH2 REMARK 470 GLN F 195 CG CD OE1 NE2 REMARK 470 LYS F 196 CG CD CE NZ REMARK 470 LEU F 201 CG CD1 CD2 REMARK 470 THR F 202 OG1 CG2 REMARK 470 GLN F 203 CG CD OE1 NE2 REMARK 470 GLU F 204 CG CD OE1 OE2 REMARK 470 GLU H 34 CG CD OE1 OE2 REMARK 470 ASN H 58 CG OD1 ND2 REMARK 470 ARG H 63 NE CZ NH1 NH2 REMARK 470 PHE H 109 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP I 143 CG OD1 OD2 REMARK 470 LYS I 171 CG CD CE NZ REMARK 470 ARG I 176 CG CD NE CZ NH1 NH2 REMARK 470 ARG I 177 CG CD NE CZ NH1 NH2 REMARK 470 ARG I 182 CG CD NE CZ NH1 NH2 REMARK 470 TYR I 185 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG I 205 CG CD NE CZ NH1 NH2 REMARK 470 ASP J 83 CG OD1 OD2 REMARK 470 GLU J 98 CG CD OE1 OE2 REMARK 470 ASP J 101 CG OD1 OD2 REMARK 470 ARG K 63 CG CD NE CZ NH1 NH2 REMARK 470 SER K 87 OG REMARK 470 ASP L 143 CG OD1 OD2 REMARK 470 LYS L 171 CG CD CE NZ REMARK 470 ARG L 177 NE CZ NH1 NH2 REMARK 470 ARG L 182 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -113.42 52.08 REMARK 500 ASP A 47 -100.65 56.18 REMARK 500 ALA A 67 67.26 -102.51 REMARK 500 ALA A 71 72.71 -152.92 REMARK 500 SER B 87 -9.68 67.05 REMARK 500 ARG C 79 55.45 -97.13 REMARK 500 ASN C 90 -173.19 -67.33 REMARK 500 SER C 111 -163.36 -121.75 REMARK 500 GLU C 199 -58.58 -152.42 REMARK 500 HIS D 10 -99.75 58.14 REMARK 500 ASP D 47 -101.83 57.18 REMARK 500 SER D 94 -177.11 -66.86 REMARK 500 PRO D 97 -110.00 -70.51 REMARK 500 GLU D 98 -41.28 -156.73 REMARK 500 LEU D 99 136.18 66.61 REMARK 500 GLU E 64 -10.10 73.07 REMARK 500 ARG F 79 50.98 -98.19 REMARK 500 ASN F 90 -174.31 -67.58 REMARK 500 SER F 111 -164.94 -121.22 REMARK 500 GLN F 132 -13.33 76.93 REMARK 500 SER F 139 -164.13 -117.67 REMARK 500 GLN F 203 93.98 -64.79 REMARK 500 HIS G 10 -114.04 52.98 REMARK 500 ASP G 47 -106.87 57.50 REMARK 500 ALA G 71 76.29 -153.60 REMARK 500 ASP G 82 -88.44 60.85 REMARK 500 VAL G 102 34.27 -91.98 REMARK 500 ASP H 111 -140.28 57.35 REMARK 500 ARG I 79 49.91 -93.93 REMARK 500 SER I 111 -164.32 -126.09 REMARK 500 GLN I 132 -4.99 71.15 REMARK 500 SER I 139 -149.29 -101.50 REMARK 500 HIS J 10 -113.98 51.38 REMARK 500 ASP J 47 -115.76 55.60 REMARK 500 ALA J 71 73.91 -152.56 REMARK 500 ASP J 82 91.52 57.70 REMARK 500 ASP J 83 -62.81 68.79 REMARK 500 MET K 45 43.62 -97.33 REMARK 500 LEU L 63 76.53 62.28 REMARK 500 ARG L 79 49.02 -95.78 REMARK 500 ASN L 90 -175.14 -69.38 REMARK 500 SER L 111 -162.89 -122.13 REMARK 500 LEU L 178 -103.64 -70.92 REMARK 500 ASP L 179 -107.67 -166.75 REMARK 500 ILE L 180 -169.40 46.98 REMARK 500 GLU L 204 59.58 -67.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH L2034 DISTANCE = 5.63 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE (V6F): REMARK 600 CAPPED HYDROXYPROLINE REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS A 60 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS A 60 SG REMARK 620 2 CAS A 60 CE1 110.2 REMARK 620 3 CAS A 60 CE2 107.3 108.8 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS A 89 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS A 89 SG REMARK 620 2 CAS A 89 CE1 109.7 REMARK 620 3 CAS A 89 CE2 110.0 109.8 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS C 77 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS C 77 SG REMARK 620 2 CAS C 77 CE1 108.9 REMARK 620 3 CAS C 77 CE2 109.7 108.5 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS D 60 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS D 60 SG REMARK 620 2 CAS D 60 CE1 107.3 REMARK 620 3 CAS D 60 CE2 109.5 109.1 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS D 89 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS D 89 CE1 REMARK 620 2 CAS D 89 SG 109.6 REMARK 620 3 CAS D 89 CE2 110.3 109.8 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS F 77 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS F 77 SG REMARK 620 2 CAS F 77 CE1 107.9 REMARK 620 3 CAS F 77 CE2 108.4 108.3 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS G 60 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS G 60 SG REMARK 620 2 CAS G 60 CE2 110.0 REMARK 620 3 CAS G 60 CE1 109.2 109.1 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS G 89 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS G 89 SG REMARK 620 2 CAS G 89 CE1 107.7 REMARK 620 3 CAS G 89 CE2 109.8 110.1 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS I 77 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS I 77 SG REMARK 620 2 CAS I 77 CE1 109.7 REMARK 620 3 CAS I 77 CE2 109.5 109.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS J 60 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS J 60 SG REMARK 620 2 CAS J 60 CE2 110.4 REMARK 620 3 CAS J 60 CE1 110.0 109.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS J 89 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS J 89 SG REMARK 620 2 CAS J 89 CE2 111.0 REMARK 620 3 CAS J 89 CE1 110.0 110.3 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CAS L 77 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CAS L 77 SG REMARK 620 2 CAS L 77 CE1 108.5 REMARK 620 3 CAS L 77 CE2 109.4 109.3 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE V6F L1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE V6F C1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE V6F F1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE V6F I1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B1113 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT L1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL J1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY F1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT F1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT I1207 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LM8 RELATED DB: PDB REMARK 900 STRUCTURE OF A HIF-1A-PVHL-ELONGINB-ELONGINC COMPLEX REMARK 900 RELATED ID: 1LQB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HYDROXYLATED HIF-1 ALPHA REMARK 900 PEPTIDEBOUND TO THE PVHL/ELONGIN-C/ELONGIN-B COMPLEX REMARK 900 RELATED ID: 1VCB RELATED DB: PDB REMARK 900 THE VHL-ELONGINC-ELONGINB STRUCTURE REMARK 900 RELATED ID: 2C9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN- REMARK 900 B AND ELONGIN-C AT 1.9A RESOLUTION REMARK 900 RELATED ID: 2IZV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN- REMARK 900 B AND ELONGIN-C AT 2.55A RESOLUTION REMARK 900 RELATED ID: 2XAI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANKYRIN REPEAT AND SOCS BOX- REMARK 900 CONTAINING PROTEIN 9 (ASB9) IN COMPLEX WITH ELONGINB REMARK 900 AND ELONGINC REMARK 900 RELATED ID: 3ZRC RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX (4R)-4-HYDROXY-1-[(3- REMARK 900 METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL REMARK 900 )BENZYL]-L-PROLINAMIDE BOUND REMARK 900 RELATED ID: 3ZRF RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX_APO REMARK 900 RELATED ID: 3ZTC RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX _ (2S,4R)-N-((1,1'- REMARK 900 BIPHENYL)-4-YLMETHYL)-4-HYDROXY-1-(2-(3-METHYLISOXAZOL REMARK 900 -5-YL)ACETYL)PYRROLIDINE-2-CARBOXAMIDE REMARK 900 RELATED ID: 3ZTD RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX _ METHYL 4-(((2S,4R)- REMARK 900 4-HYDROXY-1-(2-(3-METHYLISOXAZOL-5-YL)ACETYL) REMARK 900 PYRROLIDINE-2-CARBOXAMIDO)METHYL)BENZOATE REMARK 900 RELATED ID: 3ZUN RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX_(2S,4R)-4-HYDROXY-1-( REMARK 900 2-(3-METHYLISOXAZOL-5-YL)ACETYL)-N-(4-NITROBENZYL) REMARK 900 PYRROLIDINE-2-CARBOXAMIDE BOUND REMARK 900 RELATED ID: 4AJY RELATED DB: PDB REMARK 900 VON HIPPEL-LINDAU PROTEIN-ELONGINB-ELONGINC COMPLEX, REMARK 900 BOUND TO HIF1-ALPHA PEPTIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 GSH REMAINING AFTER THROMBIN CLEAVAGE REMARK 999 EXTRA M AT N-TERMINUS AS RESULT OF CLONING DBREF 4AWJ A 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 4AWJ B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 4AWJ C 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 4AWJ D 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 4AWJ E 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 4AWJ F 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 4AWJ G 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 4AWJ H 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 4AWJ I 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 4AWJ J 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 4AWJ K 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 4AWJ L 54 213 UNP P40337 VHL_HUMAN 54 213 SEQADV 4AWJ MET B 16 UNP Q15369 EXPRESSION TAG SEQADV 4AWJ GLY C 51 UNP P40337 EXPRESSION TAG SEQADV 4AWJ SER C 52 UNP P40337 EXPRESSION TAG SEQADV 4AWJ HIS C 53 UNP P40337 EXPRESSION TAG SEQADV 4AWJ MET E 16 UNP Q15369 EXPRESSION TAG SEQADV 4AWJ GLY F 51 UNP P40337 EXPRESSION TAG SEQADV 4AWJ SER F 52 UNP P40337 EXPRESSION TAG SEQADV 4AWJ HIS F 53 UNP P40337 EXPRESSION TAG SEQADV 4AWJ MET H 16 UNP Q15369 EXPRESSION TAG SEQADV 4AWJ GLY I 51 UNP P40337 EXPRESSION TAG SEQADV 4AWJ SER I 52 UNP P40337 EXPRESSION TAG SEQADV 4AWJ HIS I 53 UNP P40337 EXPRESSION TAG SEQADV 4AWJ MET K 16 UNP Q15369 EXPRESSION TAG SEQADV 4AWJ GLY L 51 UNP P40337 EXPRESSION TAG SEQADV 4AWJ SER L 52 UNP P40337 EXPRESSION TAG SEQADV 4AWJ HIS L 53 UNP P40337 EXPRESSION TAG SEQRES 1 A 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 A 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 A 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 B 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 B 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 B 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 B 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 B 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 B 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 B 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 B 97 ALA ASN PHE LEU ASP CYS SEQRES 1 C 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 C 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 C 163 CAS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 C 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 C 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 C 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 C 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 C 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 C 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 C 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 C 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 C 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 C 163 ALA HIS GLN ARG MET GLY ASP SEQRES 1 D 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 D 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 D 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 D 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 D 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 D 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 D 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 D 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 E 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 E 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 E 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 E 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 E 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 E 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 E 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 E 97 ALA ASN PHE LEU ASP CYS SEQRES 1 F 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 F 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 F 163 CAS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 F 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 F 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 F 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 F 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 F 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 F 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 F 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 F 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 F 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 F 163 ALA HIS GLN ARG MET GLY ASP SEQRES 1 G 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 G 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 G 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 G 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 G 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 G 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 G 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 G 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 H 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 H 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 H 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 H 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 H 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 H 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 H 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 H 97 ALA ASN PHE LEU ASP CYS SEQRES 1 I 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 I 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 I 163 CAS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 I 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 I 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 I 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 I 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 I 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 I 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 I 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 I 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 I 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 I 163 ALA HIS GLN ARG MET GLY ASP SEQRES 1 J 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 J 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 J 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 J 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 J 104 ASP GLY LYS THR LEU GLY GLU CAS GLY PHE THR SER GLN SEQRES 6 J 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 J 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 J 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 K 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 K 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 K 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 K 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 K 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 K 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 K 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 K 97 ALA ASN PHE LEU ASP CYS SEQRES 1 L 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 L 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 L 163 CAS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 L 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 L 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 L 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 L 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 L 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 L 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 L 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 L 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 L 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 L 163 ALA HIS GLN ARG MET GLY ASP MODRES 4AWJ CAS A 60 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS A 89 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS C 77 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS D 60 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS D 89 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS F 77 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS G 60 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS G 89 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS I 77 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS J 60 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS J 89 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4AWJ CAS L 77 CYS S-(DIMETHYLARSENIC)CYSTEINE HET CAS A 60 9 HET CAS A 89 9 HET CAS C 77 9 HET CAS D 60 9 HET CAS D 89 9 HET CAS F 77 9 HET CAS G 60 9 HET CAS G 89 9 HET CAS I 77 9 HET CAS J 60 9 HET CAS J 89 9 HET CAS L 77 9 HET V6F L1206 13 HET V6F C1201 13 HET V6F F1205 13 HET V6F I1206 13 HET ACT A1104 4 HET ACT B1113 4 HET ACT L1207 4 HET ACT C1202 4 HET GOL J1104 6 HET ACY F1206 4 HET ACT F1207 4 HET ACT I1207 4 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM ACT ACETATE ION HETNAM V6F (4R)-1-ACETYL-4-HYDROXY-N-METHYL-L-PROLINAMIDE HETNAM ACY ACETIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CAS 12(C5 H12 AS N O2 S) FORMUL 2 ACT 6(C2 H3 O2 1-) FORMUL 3 V6F 4(C8 H14 N2 O3) FORMUL 4 ACY C2 H4 O2 FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *289(H2 O) HELIX 1 1 THR A 23 LYS A 36 1 14 HELIX 2 2 PRO A 38 ASP A 40 5 3 HELIX 3 3 ARG B 33 LEU B 37 1 5 HELIX 4 4 SER B 39 SER B 47 1 9 HELIX 5 5 PRO B 66 THR B 84 1 19 HELIX 6 6 ALA B 96 ASP B 111 1 16 HELIX 7 7 THR C 157 SER C 168 1 12 HELIX 8 8 LYS C 171 ARG C 176 5 6 HELIX 9 9 VAL C 181 ASP C 190 1 10 HELIX 10 10 ASN C 193 LEU C 198 1 6 HELIX 11 11 THR D 23 LYS D 36 1 14 HELIX 12 12 PRO D 38 ASP D 40 5 3 HELIX 13 13 ARG E 33 LEU E 37 1 5 HELIX 14 14 SER E 39 SER E 47 1 9 HELIX 15 15 PRO E 66 THR E 84 1 19 HELIX 16 16 ILE E 99 ASP E 111 1 13 HELIX 17 17 ASN F 141 GLN F 145 5 5 HELIX 18 18 THR F 157 SER F 168 1 12 HELIX 19 19 LYS F 171 LEU F 178 5 8 HELIX 20 20 VAL F 181 ASP F 190 1 10 HELIX 21 21 ASN F 193 GLN F 203 1 11 HELIX 22 22 THR G 23 LYS G 36 1 14 HELIX 23 23 PRO G 38 ASP G 40 5 3 HELIX 24 24 LEU G 57 GLY G 61 5 5 HELIX 25 25 ARG H 33 LEU H 37 1 5 HELIX 26 26 THR H 41 LEU H 46 1 6 HELIX 27 27 PRO H 66 THR H 84 1 19 HELIX 28 28 ALA H 96 GLU H 98 5 3 HELIX 29 29 ILE H 99 ASP H 111 1 13 HELIX 30 30 THR I 157 VAL I 170 1 14 HELIX 31 31 LYS I 171 ARG I 176 5 6 HELIX 32 32 VAL I 181 ASP I 190 1 10 HELIX 33 33 ASN I 193 GLU I 204 1 12 HELIX 34 34 THR J 23 LYS J 36 1 14 HELIX 35 35 PRO J 38 ASP J 40 5 3 HELIX 36 36 ARG K 33 LEU K 37 1 5 HELIX 37 37 SER K 39 MET K 45 1 7 HELIX 38 38 PRO K 66 THR K 84 1 19 HELIX 39 39 ILE K 99 ASP K 111 1 13 HELIX 40 40 THR L 157 VAL L 170 1 14 HELIX 41 41 LYS L 171 LEU L 178 5 8 HELIX 42 42 VAL L 181 ASP L 190 1 10 HELIX 43 43 ASN L 193 GLU L 204 1 12 SHEET 1 AA 8 GLN A 49 LEU A 50 0 SHEET 2 AA 8 GLN A 42 LYS A 46 -1 O LYS A 46 N GLN A 49 SHEET 3 AA 8 ALA A 73 PHE A 79 -1 O GLY A 76 N TYR A 45 SHEET 4 AA 8 ASP A 2 ARG A 9 1 O PHE A 4 N ALA A 73 SHEET 5 AA 8 THR A 12 LYS A 19 -1 O THR A 12 N ARG A 9 SHEET 6 AA 8 GLU B 28 LYS B 32 1 O GLU B 28 N THR A 13 SHEET 7 AA 8 TYR B 18 ILE B 22 -1 O VAL B 19 N VAL B 31 SHEET 8 AA 8 GLU B 59 ASN B 61 1 O VAL B 60 N ILE B 22 SHEET 1 CA 4 GLY C 106 TYR C 112 0 SHEET 2 CA 4 PRO C 71 ARG C 79 -1 O SER C 72 N SER C 111 SHEET 3 CA 4 ILE C 147 THR C 152 1 O ILE C 147 N ILE C 75 SHEET 4 CA 4 LEU C 129 VAL C 130 -1 O LEU C 129 N THR C 152 SHEET 1 CB 3 PRO C 95 PRO C 97 0 SHEET 2 CB 3 VAL C 84 LEU C 89 -1 O TRP C 88 N GLN C 96 SHEET 3 CB 3 LEU C 116 ASP C 121 -1 O LEU C 116 N LEU C 89 SHEET 1 DA 8 GLN D 49 LEU D 50 0 SHEET 2 DA 8 GLN D 42 LYS D 46 -1 O LYS D 46 N GLN D 49 SHEET 3 DA 8 ALA D 73 PHE D 79 -1 O GLY D 76 N TYR D 45 SHEET 4 DA 8 ASP D 2 ARG D 9 1 O PHE D 4 N ALA D 73 SHEET 5 DA 8 THR D 12 LYS D 19 -1 O THR D 12 N ARG D 9 SHEET 6 DA 8 GLU E 28 LYS E 32 1 O GLU E 28 N THR D 13 SHEET 7 DA 8 TYR E 18 ILE E 22 -1 O VAL E 19 N VAL E 31 SHEET 8 DA 8 GLU E 59 ASN E 61 1 O VAL E 60 N ILE E 22 SHEET 1 FA 4 GLY F 106 TYR F 112 0 SHEET 2 FA 4 PRO F 71 ARG F 79 -1 O SER F 72 N SER F 111 SHEET 3 FA 4 ILE F 147 THR F 152 1 O ILE F 147 N ILE F 75 SHEET 4 FA 4 LEU F 129 VAL F 130 -1 O LEU F 129 N THR F 152 SHEET 1 FB 3 PRO F 95 PRO F 97 0 SHEET 2 FB 3 VAL F 84 LEU F 89 -1 O TRP F 88 N GLN F 96 SHEET 3 FB 3 LEU F 116 ASP F 121 -1 O LEU F 116 N LEU F 89 SHEET 1 GA 4 GLN G 49 LEU G 50 0 SHEET 2 GA 4 GLN G 42 LYS G 46 -1 O LYS G 46 N GLN G 49 SHEET 3 GA 4 ALA G 73 ALA G 81 -1 O GLY G 76 N TYR G 45 SHEET 4 GA 4 THR G 84 PHE G 85 1 O THR G 84 N ALA G 81 SHEET 1 GB 8 GLN G 49 LEU G 50 0 SHEET 2 GB 8 GLN G 42 LYS G 46 -1 O LYS G 46 N GLN G 49 SHEET 3 GB 8 ALA G 73 ALA G 81 -1 O GLY G 76 N TYR G 45 SHEET 4 GB 8 ASP G 2 ARG G 9 1 O PHE G 4 N ALA G 73 SHEET 5 GB 8 THR G 12 LYS G 19 -1 O THR G 12 N ARG G 9 SHEET 6 GB 8 GLU H 28 LYS H 32 1 O GLU H 28 N THR G 13 SHEET 7 GB 8 TYR H 18 ILE H 22 -1 O VAL H 19 N VAL H 31 SHEET 8 GB 8 GLU H 59 ASN H 61 1 O VAL H 60 N ILE H 22 SHEET 1 GC 2 THR G 84 PHE G 85 0 SHEET 2 GC 2 ALA G 73 ALA G 81 1 N ALA G 81 O THR G 84 SHEET 1 IA 7 PRO I 95 PRO I 97 0 SHEET 2 IA 7 VAL I 84 LEU I 89 -1 O TRP I 88 N GLN I 96 SHEET 3 IA 7 LEU I 116 ASP I 121 -1 O LEU I 116 N LEU I 89 SHEET 4 IA 7 GLY I 127 VAL I 130 -1 O LEU I 128 N PHE I 119 SHEET 5 IA 7 ILE I 147 THR I 152 -1 O THR I 152 N LEU I 129 SHEET 6 IA 7 PRO I 71 ARG I 79 1 O GLN I 73 N ILE I 147 SHEET 7 IA 7 GLY I 106 TYR I 112 -1 O ARG I 107 N PHE I 76 SHEET 1 JA 4 GLN J 49 LEU J 50 0 SHEET 2 JA 4 GLN J 42 LYS J 46 -1 O LYS J 46 N GLN J 49 SHEET 3 JA 4 ALA J 73 ALA J 81 -1 O GLY J 76 N TYR J 45 SHEET 4 JA 4 THR J 84 PHE J 85 1 O THR J 84 N ALA J 81 SHEET 1 JB 8 GLN J 49 LEU J 50 0 SHEET 2 JB 8 GLN J 42 LYS J 46 -1 O LYS J 46 N GLN J 49 SHEET 3 JB 8 ALA J 73 ALA J 81 -1 O GLY J 76 N TYR J 45 SHEET 4 JB 8 ASP J 2 ARG J 9 1 O PHE J 4 N ALA J 73 SHEET 5 JB 8 THR J 12 LYS J 19 -1 O THR J 12 N ARG J 9 SHEET 6 JB 8 GLU K 28 LYS K 32 1 O GLU K 28 N THR J 13 SHEET 7 JB 8 TYR K 18 ILE K 22 -1 O VAL K 19 N VAL K 31 SHEET 8 JB 8 GLU K 59 ASN K 61 1 O VAL K 60 N ILE K 22 SHEET 1 JC 2 THR J 84 PHE J 85 0 SHEET 2 JC 2 ALA J 73 ALA J 81 1 O ALA J 81 N THR J 84 SHEET 1 LA 4 GLY L 106 TYR L 112 0 SHEET 2 LA 4 PRO L 71 ARG L 79 -1 O SER L 72 N SER L 111 SHEET 3 LA 4 ILE L 147 THR L 152 1 O ILE L 147 N ILE L 75 SHEET 4 LA 4 LEU L 129 VAL L 130 -1 O LEU L 129 N THR L 152 SHEET 1 LB 3 PRO L 95 PRO L 97 0 SHEET 2 LB 3 VAL L 84 LEU L 89 -1 O TRP L 88 N GLN L 96 SHEET 3 LB 3 LEU L 116 ASP L 121 -1 O LEU L 116 N LEU L 89 LINK N CAS A 60 C GLU A 59 1555 1555 1.33 LINK C CAS A 60 N GLY A 61 1555 1555 1.33 LINK N CAS A 89 C LEU A 88 1555 1555 1.33 LINK C CAS A 89 N ILE A 90 1555 1555 1.33 LINK N CAS C 77 C PHE C 76 1555 1555 1.33 LINK C CAS C 77 N ASN C 78 1555 1555 1.33 LINK N CAS D 60 C GLU D 59 1555 1555 1.33 LINK C CAS D 60 N GLY D 61 1555 1555 1.33 LINK N CAS D 89 C LEU D 88 1555 1555 1.33 LINK C CAS D 89 N ILE D 90 1555 1555 1.33 LINK N CAS F 77 C PHE F 76 1555 1555 1.33 LINK C CAS F 77 N ASN F 78 1555 1555 1.33 LINK C CAS G 60 N GLY G 61 1555 1555 1.33 LINK N CAS G 60 C GLU G 59 1555 1555 1.33 LINK C CAS G 89 N ILE G 90 1555 1555 1.33 LINK N CAS G 89 C LEU G 88 1555 1555 1.33 LINK C CAS I 77 N ASN I 78 1555 1555 1.33 LINK N CAS I 77 C PHE I 76 1555 1555 1.33 LINK C CAS J 60 N GLY J 61 1555 1555 1.33 LINK N CAS J 60 C GLU J 59 1555 1555 1.33 LINK C CAS J 89 N ILE J 90 1555 1555 1.33 LINK N CAS J 89 C LEU J 88 1555 1555 1.33 LINK C CAS L 77 N ASN L 78 1555 1555 1.33 LINK N CAS L 77 C PHE L 76 1555 1555 1.33 SITE 1 AC1 7 TRP L 88 TYR L 98 HIS L 110 SER L 111 SITE 2 AC1 7 TYR L 112 HIS L 115 TRP L 117 SITE 1 AC2 7 TRP C 88 TYR C 98 HIS C 110 SER C 111 SITE 2 AC2 7 TYR C 112 HIS C 115 TRP C 117 SITE 1 AC3 7 TRP F 88 TYR F 98 HIS F 110 SER F 111 SITE 2 AC3 7 TYR F 112 HIS F 115 TRP F 117 SITE 1 AC4 7 TRP I 88 TYR I 98 HIS I 110 SER I 111 SITE 2 AC4 7 TYR I 112 HIS I 115 TRP I 117 SITE 1 AC5 3 HIS A 10 LYS A 11 THR A 12 SITE 1 AC6 4 TYR B 18 VAL B 19 LYS B 20 ILE B 30 SITE 1 AC7 1 ARG L 161 SITE 1 AC8 2 ARG C 82 ARG C 161 SITE 1 AC9 7 PHE J 4 LEU J 5 PHE J 15 THR J 16 SITE 2 AC9 7 PRO J 69 PRO J 72 THR K 78 SITE 1 BC1 2 ARG F 167 LYS F 171 SITE 1 BC2 1 ARG F 161 SITE 1 BC3 1 ARG I 161 CRYST1 93.400 93.400 362.040 90.00 90.00 90.00 P 41 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010707 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010707 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002762 0.00000